A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions

Journal of Critical Care

Volumn 18, Issue 2, 2003, Pages 121-129

  Tobe, Sheldon W ^a   Aujla, Prince ^b   Walele, Aziz A ^b   Oliver, Matthew J ^b   Naimark, David M J ^b   Perkins, Nancy J ^b   Beardsall, Marianne ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACD A; ACID CITRATE DEXTROSE; ANTICOAGULANT AGENT; HEPARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTINUOUS RENAL REPLACEMENT THERAPY; DIALYSIS; DRUG SAFETY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; NURSING; SIDE EFFECT; SURVIVAL; TEACHING HOSPITAL; UNIVERSITY HOSPITAL;

EID: 0038311022     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcrc.2003.50006     Document Type: Article

References (23)

1. Mehta RL, McDonald BR, Aguilar MM, et al: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976-981, 1990
2. Palsson R, Niles JL: Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55:1991-1997, 1999
3. Hofbauer R, Moser D, Frass M, et al: Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int 56:1578-1583, 1999
4. Garred L, Leblanc M, Canaud B, et al: Kinetic modeling for CRRT. Am J Kidney Dis 30:S2-S9, 1997
5. Kutsogiannis DJ, Mayers I, Chin WD, et al: Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 35:802-811, 2000
6. Ashton DN, Mehta RL, Ward DM, et al: Recent advances in continuous renal replacement therapy: Citrate anticoagulated continuous arteriovenous hemodialysis. Nephrol Nurs J 18:263-267, 2000
7. Mehta RL: Continuous renal replacement therapies in the acute renal failure setting: Current concepts. Adv Ren Replace Ther 4:81-92, 1997
8. Pereira BJ, Snodgrass BR, Hogan PJ, et al: Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes. Kidney Int 47:603-610, 1995
9. Ward DM, Mehta RL: Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 41:S237-S244, 1993 (suppl)
10. Palsson R, Niles JL: Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55:1991-1997, 1999
11. Flanigan MJ, Pillsbury L, Sadewasser G, et al: Regional hemodialysis anticoagulation: Hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A. Am J Kidney Dis 27:519-524, 1996
12. Macdonald D, Martin R: Use of sodium citrate anticoagulation in a pediatric continuous venovenous hemodialysis patient, Nephrol Nurs J 22:327-328, 1995
13. Leblanc M, Moreno L, Robinson OP, et al: Bicarbonate dialysate for continuous renal replacement therapy in intensive care unit patients with acute renal failure. Am J Kidney Dis 26:910-917, 1995
14. Mehta RL: Anticoagulation during continuous renal replacement therapy. ASAIO J 40:931-935, 1994
15. Abramson S, Niles JL: Anticoagulation in continuous renal replacement therapy. Curr Opin Nephrol Hypertens 8:701-707, 1999
16. Davenport A: Management of heparin-induced thrombocytopenia during continuous renal replacement therapy. Am J Kidney Dis 32:E3, 1998
17. Rock G, Tittley P, Fuller V: Effect of citrate anticoagulants on factor VIII levels in plasma. Transfusion 28:248-252, 1988
18. Barbour C, Devenish L, Locke J, et al: Regional anticoagulation using anticoagulant citrate dextrose solution in conjunction with commercially prepared dialysate solutions containing calcium in continuous venovenous hemodiafiltration. Blood Purif 17:19, 1999 (abstr)
19. Bunchman TE, Maxvold NJ, Barnett J, et al: Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation, Pediatr Nephrol 17:150-154, 2002
20. Zimmerman D, Cotman P, Ting R, et al: Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: Prospective cross-over comparison with a lactate buffered solution. Nephrol Dial Transplant 14:2387-2391, 1999
21. Kierdorf HP, Leue C, Arns S: Lactate- or bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies. Kidney Int 72:S32-S36, 1999 (suppl)
22. McLean AG, Davenport A, Cox D, et al: Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction. Kidney Int 58:1765-1772, 2000
23. Barenbrock M, Hausberg M, Matzkies F, et al: Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int 58:1751-1757, 2000